HEADER CELL ADHESION 08-JUL-15 5CFV TITLE FUSION OF MALTOSE-BINDING PROTEIN AND PILA FROM ACINETOBACTER TITLE 2 NOSOCOMIALIS M2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTOSE-BINDING PERIPLASMIC PROTEIN,MALTOSE-BINDING COMPND 3 PERIPLASMIC PROTEIN,PILA FUSION PROTEIN; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: MBP,MMBP,MALTODEXTRIN-BINDING PROTEIN,MBP,MMBP,MALTODEXTRIN- COMPND 6 BINDING PROTEIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI, ACINETOBACTER NOSOCOMIALIS SOURCE 3 M2; SOURCE 4 ORGANISM_TAXID: 83333, 1343071; SOURCE 5 STRAIN: K12; SOURCE 6 GENE: MALE, B4034, JW3994, PILA; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS ADHESION, EXTRACELLULAR APPENDAGE, FIMBRIAE, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR K.H.PIEPENBRINK,E.J.SUNDBERG REVDAT 6 23-OCT-24 5CFV 1 HETSYN REVDAT 5 29-JUL-20 5CFV 1 COMPND JRNL REMARK HET REVDAT 5 2 1 HETNAM HETSYN FORMUL LINK REVDAT 5 3 1 SITE ATOM REVDAT 4 09-NOV-16 5CFV 1 JRNL REVDAT 3 28-SEP-16 5CFV 1 JRNL REVDAT 2 21-SEP-16 5CFV 1 JRNL REVDAT 1 13-JUL-16 5CFV 0 JRNL AUTH K.H.PIEPENBRINK,E.LILLEHOJ,C.M.HARDING,J.W.LABONTE,X.ZUO, JRNL AUTH 2 C.A.RAPP,R.S.MUNSON,S.E.GOLDBLUM,M.F.FELDMAN,J.J.GRAY, JRNL AUTH 3 E.J.SUNDBERG JRNL TITL STRUCTURAL DIVERSITY IN THE TYPE IV PILI OF JRNL TITL 2 MULTIDRUG-RESISTANT ACINETOBACTER. JRNL REF J.BIOL.CHEM. V. 291 22924 2016 JRNL REFN ESSN 1083-351X JRNL PMID 27634041 JRNL DOI 10.1074/JBC.M116.751099 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9-1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 150644 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.09 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CFV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000211552. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.034 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.9 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42472 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 29.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: DROPS WERE SET AT A RATIO OF 2:1 REMARK 280 MOTHER-LIQUOR TO PROTEIN, AT 10MG/ML PROTEIN CONCENTRATION. THE REMARK 280 MOTHER-LIQUOR CONSISTED OF 0.1M BICINE/TRIZMA PH 8.0, 0.06M REMARK 280 MGCL2, 0.06M CACL2, 25% MPD, 25% PEG3350, 25% PEG400, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 86.94150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.66700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 86.94150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.66700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 LYS A 1 REMARK 465 SER A 1138 REMARK 465 LEU A 1139 REMARK 465 GLU A 1140 REMARK 465 HIS A 1141 REMARK 465 HIS A 1142 REMARK 465 HIS A 1143 REMARK 465 HIS A 1144 REMARK 465 HIS A 1145 REMARK 465 HIS A 1146 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 82 CG OD1 OD2 REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 GLU A 172 CG CD OE1 OE2 REMARK 470 ASN A 173 CG OD1 ND2 REMARK 470 LYS A 239 CG CD CE NZ REMARK 470 GLU A 359 CG CD OE1 OE2 REMARK 470 LYS A 362 CG CD CE NZ REMARK 470 ASP A 363 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 184 O HOH A 1301 1.96 REMARK 500 OD1 ASP A 184 O HOH A 1302 2.05 REMARK 500 OD1 ASP A 184 O HOH A 1303 2.08 REMARK 500 O HOH A 1339 O HOH A 1504 2.11 REMARK 500 O HOH A 1430 O HOH A 1502 2.15 REMARK 500 O GLU A 153 O HOH A 1304 2.16 REMARK 500 O HOH A 1320 O HOH A 1457 2.17 REMARK 500 O HOH A 1358 O HOH A 1494 2.17 REMARK 500 O HOH A 1302 O HOH A 1352 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 55 -159.56 -110.16 REMARK 500 ALA A 168 -75.06 -83.93 REMARK 500 ASP A 184 47.90 -97.20 REMARK 500 ASP A 184 55.94 -103.00 REMARK 500 ASP A 209 -169.19 -123.56 REMARK 500 TYR A 283 -55.83 -123.95 REMARK 500 ALA A1058 -142.83 25.68 REMARK 500 ALA A1083 -131.61 59.40 REMARK 500 ASN A1085 78.09 -101.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1207 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 120 OD1 REMARK 620 2 HOH A1302 O 138.8 REMARK 620 3 HOH A1306 O 98.6 64.1 REMARK 620 4 HOH A1352 O 163.7 57.4 90.4 REMARK 620 5 HOH A1403 O 83.1 129.7 88.1 83.7 REMARK 620 6 HOH A1426 O 87.6 62.8 102.4 103.8 167.0 REMARK 620 7 HOH A1451 O 80.2 123.8 168.8 88.3 80.7 88.8 REMARK 620 N 1 2 3 4 5 6 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SOK RELATED DB: PDB REMARK 900 3SOK CONTAINS A RELATED PILIN PROTEIN FROM DICHELOBACTER NODOSUS REMARK 900 RELATED ID: 4XA2 RELATED DB: PDB REMARK 900 4XA2 CONTAINS A RELATED PILIN PROTEIN FROM ACINETOBACTER BAUMANNII REMARK 900 ACICU DBREF 5CFV A 1 366 UNP P0AEX9 MALE_ECOLI 27 392 DBREF 5CFV A 367 1146 PDB 5CFV 5CFV 367 1146 SEQADV 5CFV MET A 0 UNP P0AEX9 INITIATING METHIONINE SEQADV 5CFV ALA A 87 UNP P0AEX9 ASP 113 ENGINEERED MUTATION SEQADV 5CFV ALA A 88 UNP P0AEX9 LYS 114 ENGINEERED MUTATION SEQRES 1 A 495 MET LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE ASN SEQRES 2 A 495 GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY LYS SEQRES 3 A 495 LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL GLU SEQRES 4 A 495 HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL ALA SEQRES 5 A 495 ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA HIS SEQRES 6 A 495 ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU ALA SEQRES 7 A 495 GLU ILE THR PRO ASP LYS ALA PHE GLN ALA ALA LEU TYR SEQRES 8 A 495 PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS LEU SEQRES 9 A 495 ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU ILE SEQRES 10 A 495 TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR TRP SEQRES 11 A 495 GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA LYS SEQRES 12 A 495 GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO TYR SEQRES 13 A 495 PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR ALA SEQRES 14 A 495 PHE LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS ASP VAL SEQRES 15 A 495 GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR PHE SEQRES 16 A 495 LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA ASP SEQRES 17 A 495 THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS GLY SEQRES 18 A 495 GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SER SEQRES 19 A 495 ASN ILE ASP THR SER LYS VAL ASN TYR GLY VAL THR VAL SEQRES 20 A 495 LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE VAL SEQRES 21 A 495 GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO ASN SEQRES 22 A 495 LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU LEU SEQRES 23 A 495 THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS PRO SEQRES 24 A 495 LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU LEU SEQRES 25 A 495 ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN ALA SEQRES 26 A 495 GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SER SEQRES 27 A 495 ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN ALA SEQRES 28 A 495 ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS ASP SEQRES 29 A 495 ALA GLN THR ASN ALA ALA ALA ALA TYR GLN ASN TYR ILE SEQRES 30 A 495 ALA LYS SER GLN ALA SER GLU ALA PHE THR LEU ALA ASP SEQRES 31 A 495 GLY LEU LYS THR THR ILE ASN THR ASN LEU GLN ALA GLY SEQRES 32 A 495 THR CYS PHE ALA GLY GLY ALA THR ALA VAL THR ALA ALA SEQRES 33 A 495 ASP LYS VAL SER GLY LYS TYR GLY ASP ALA GLU ILE GLY SEQRES 34 A 495 GLY THR ALA PRO ASN CYS THR ILE THR TYR THR PHE LYS SEQRES 35 A 495 SER SER GLY VAL SER ASN LYS LEU THR SER THR LYS ILE SEQRES 36 A 495 VAL MET ASN VAL SER GLU THR GLY ILE LEU THR LYS ASN SEQRES 37 A 495 SER GLY THR ASP THR PRO VAL GLU LEU LEU PRO GLN SER SEQRES 38 A 495 PHE VAL ALA SER GLY SER LEU GLU HIS HIS HIS HIS HIS SEQRES 39 A 495 HIS HET GLC B 1 12 HET GLC B 2 11 HET MPD A1202 8 HET GOL A1203 6 HET GOL A1204 6 HET GOL A1205 6 HET MG A1206 1 HET MG A1207 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM GOL GLYCEROL HETNAM MG MAGNESIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GLC 2(C6 H12 O6) FORMUL 3 MPD C6 H14 O2 FORMUL 4 GOL 3(C3 H8 O3) FORMUL 7 MG 2(MG 2+) FORMUL 9 HOH *238(H2 O) HELIX 1 AA1 GLY A 16 GLY A 32 1 17 HELIX 2 AA2 LYS A 42 THR A 53 1 12 HELIX 3 AA3 ARG A 66 SER A 73 1 8 HELIX 4 AA4 ASP A 82 ALA A 87 1 6 HELIX 5 AA5 TYR A 90 VAL A 97 1 8 HELIX 6 AA6 THR A 128 GLU A 130 5 3 HELIX 7 AA7 GLU A 131 ALA A 141 1 11 HELIX 8 AA8 GLU A 153 ASP A 164 1 12 HELIX 9 AA9 ASN A 185 ASN A 201 1 17 HELIX 10 AB1 ASP A 209 LYS A 219 1 11 HELIX 11 AB2 GLY A 228 TRP A 230 5 3 HELIX 12 AB3 ALA A 231 THR A 237 1 7 HELIX 13 AB4 ASN A 272 TYR A 283 1 12 HELIX 14 AB5 THR A 286 LYS A 297 1 12 HELIX 15 AB6 LEU A 304 ALA A 312 1 9 HELIX 16 AB7 ASP A 314 GLY A 327 1 14 HELIX 17 AB8 GLN A 335 SER A 352 1 18 HELIX 18 AB9 THR A 356 ASP A 363 1 8 HELIX 19 AC1 ASP A 363 SER A 1034 1 20 HELIX 20 AC2 SER A 1034 LEU A 1051 1 18 HELIX 21 AC3 THR A 1065 ALA A 1067 5 3 HELIX 22 AC4 PRO A 1125 LEU A 1129 5 5 HELIX 23 AC5 PRO A 1130 GLY A 1137 1 8 SHEET 1 AA1 6 LYS A 34 GLU A 38 0 SHEET 2 AA1 6 LYS A 6 TRP A 10 1 N ILE A 9 O GLU A 38 SHEET 3 AA1 6 ILE A 59 ALA A 63 1 O ILE A 59 N TRP A 10 SHEET 4 AA1 6 PHE A 258 ILE A 266 -1 O SER A 263 N TRP A 62 SHEET 5 AA1 6 TYR A 106 GLU A 111 -1 N GLU A 111 O GLY A 260 SHEET 6 AA1 6 ALA A 301 VAL A 302 -1 O ALA A 301 N VAL A 110 SHEET 1 AA2 5 LYS A 34 GLU A 38 0 SHEET 2 AA2 5 LYS A 6 TRP A 10 1 N ILE A 9 O GLU A 38 SHEET 3 AA2 5 ILE A 59 ALA A 63 1 O ILE A 59 N TRP A 10 SHEET 4 AA2 5 PHE A 258 ILE A 266 -1 O SER A 263 N TRP A 62 SHEET 5 AA2 5 GLU A 328 ILE A 329 1 O GLU A 328 N VAL A 259 SHEET 1 AA3 2 ARG A 98 TYR A 99 0 SHEET 2 AA3 2 LYS A 102 LEU A 103 -1 O LYS A 102 N TYR A 99 SHEET 1 AA4 4 SER A 145 LEU A 147 0 SHEET 2 AA4 4 THR A 222 ASN A 227 1 O ALA A 223 N SER A 145 SHEET 3 AA4 4 SER A 114 ASN A 118 -1 N ASN A 118 O ALA A 223 SHEET 4 AA4 4 TYR A 242 THR A 245 -1 O THR A 245 N LEU A 115 SHEET 1 AA5 2 TYR A 167 GLU A 172 0 SHEET 2 AA5 2 LYS A 175 GLY A 182 -1 O ASP A 177 N LYS A 170 SHEET 1 AA6 2 THR A 249 PHE A 250 0 SHEET 2 AA6 2 GLN A 253 PRO A 254 -1 O GLN A 253 N PHE A 250 SHEET 1 AA7 5 LYS A1069 SER A1071 0 SHEET 2 AA7 5 GLY A1075 THR A1082 -1 O ALA A1077 N VAL A1070 SHEET 3 AA7 5 ASN A1085 PHE A1092 -1 O THR A1091 N ASP A1076 SHEET 4 AA7 5 LYS A1105 VAL A1110 -1 O MET A1108 N ILE A1088 SHEET 5 AA7 5 LEU A1116 LYS A1118 -1 O THR A1117 N ASN A1109 SSBOND 1 CYS A 1056 CYS A 1086 1555 1555 2.04 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.41 LINK OD1 ASP A 120 MG MG A1207 1555 1555 2.24 LINK MG MG A1207 O HOH A1302 1555 1554 2.44 LINK MG MG A1207 O HOH A1306 1555 1554 2.25 LINK MG MG A1207 O HOH A1352 1555 1554 2.05 LINK MG MG A1207 O HOH A1403 1555 1555 2.18 LINK MG MG A1207 O HOH A1426 1555 1554 1.91 LINK MG MG A1207 O HOH A1451 1555 1555 2.27 CRYST1 173.883 55.334 49.670 90.00 91.52 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005751 0.000000 0.000153 0.00000 SCALE2 0.000000 0.018072 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020140 0.00000